RecruitingNCT06224023
Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure
Sponsor
Carol Davila University of Medicine and Pharmacy
Enrollment
30 participants
Start Date
Aug 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- patient with ascites and chronic liver failure
- no contraindications and technical possibility to perform diagnostic paracentesis
- age above 18 years old
- informed consent
Exclusion Criteria2
- contraindications to paracentesis or technical impossibility to perform paracentesis
- absence of informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTDetermination of presepsin levels in ascites
A diagnostic paracentesis will be performed and presepsin level will be determined in ascites.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06224023
Related Trials
Early TIPS in Patients With Liver Cirrhosis and Ascites
NCT065769341 location
Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome
NCT073128641 location
Safety and Effectiveness of Mesenchymal Stem Cells in Blood Purification for the Treatment of Liver Failure
NCT069047551 location
A Study on Relationship Between Resected Normal Liver Parenchymal Volume（RNLV）and Post-Hepatectomy Liver Failure (PHLF)
NCT063660483 locations
Online Prehabilitation for Patients Awaiting Liver Transplantation
NCT058992316 locations